Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists

  • Ann N Y Acad Sci. 1994 Mar 23:713:360-3. doi: 10.1111/j.1749-6632.1994.tb44093.x.
S Patel  1 ,  K L Chapman ,  A J Smith ,  A Heald ,  S B Freedman
Affiliations
  • 1. Merck Sharp & Dohme Research Laboratories, Department of Biochemistry, Harlow, Essex, England.
PMID: 8185188 DOI: 10.1111/j.1749-6632.1994.tb44093.x
Products